Showing results (381-390 of 645) with videos related to
Sort By:
Pageof 65
Journal of Clinical Anesthesia|August 1, 1997
Clinical analysis of the flexor hallucis brevis as an alternative site for monitoring neuromuscular block from mivacuriumS E Kern, J O Johnson, J A Orr, et al.Applied Immunohistochemistry & Molecular Morphology : AIMM|August 11, 2000
Immunohistochemical p16INK4a analysis of archival tumors with deletion, hypermethylation, or mutation of the CDKN2/MTS1 gene. A comparison of four commercial antibodiesJ Geradts, R H Hruban, M Schutte, et al.Anesthesia and Analgesia|May 1, 1994
An effectiveness study of a new piezoelectric sensor for train-of-four measurementS E Kern, J O Johnson, D R Westenskow, et al.Anesthesia and Analgesia|June 24, 2003
The pharmacokinetics and pharmacodynamics of propofol in a modified cyclodextrin formulation (Captisol) versus propofol in a lipid formulation (Diprivan): an electroencephalographic and hemodynamic study in a porcine modelTalmage D Egan, Steven E Kern, Kenward B Johnson, et al.Cell|June 14, 1991
Wild-type but not mutant p53 immunopurified proteins bind to sequences adjacent to the SV40 origin of replicationJ Bargonetti, P N Friedman, S E Kern, et al.The American Journal of Pathology|January 12, 2002
Exploring the host desmoplastic response to pancreatic carcinoma: gene expression of stromal and neoplastic cells at the site of primary invasionChristine A Iacobuzio-Donahue, Byungwoo Ryu, Ralph H Hruban, et al.JAMA|September 8, 2005
Costs and funding for published medical education researchDarcy A Reed, David E Kern, Rachel B Levine, et al.Contraception|May 26, 2005
Interaction of St. John's Wort with oral contraceptives: effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity and breakthrough bleedingPatricia A Murphy, Steven E Kern, Frank Z Stanczyk, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1986
Requirement for recognition of class II molecules and processed tumor antigen for optimal generation of syngeneic tumor-specific class I-restricted CTLD E Kern, J P Klarnet, M C Jensen, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1985
Interleukin 2 (IL 2) administered in vivo: influence of IL 2 route and timing on T cell growthM A Cheever, J A Thompson, D E Kern, et al.Pageof 65